Donna McEachern
Biochemistry, Genetics and Molecular Biology · University of Michigan
Established · publishing since 1989Rising activity
Protein Degradation and InhibitorsUbiquitin and proteasome pathwaysCancer-related Molecular PathwaysMultiple Myeloma Research and TreatmentsCell death mechanisms and regulation
Publications
179
Citations
7,778
Est. group size
~34
Recurring co-author estimate
Active years
38
Publishing since 1989
In context
Among 1,668 established Biochemistry, Genetics and Molecular Biology PIs within our index
Citations: 7,778p25 1,237 · p75 8,666 · cohort median 3,422
Publications / year (recent): 19.4p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~7 · 0% small-team papers (≤3 authors) · across 2 venues
Publication cadence
Publications per year over the last 10 years — averaging 19.4/year recently
Recent publications
- Supplemental Figure S9 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Table S1, Table S2 and Table S3 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S5 and Figure S6 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S4 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S3 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S7 and Figure S8 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S1 and Figure S2. from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S10 and Figure S11 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Data from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Data from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S9 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S1 and Figure S2. from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S7 and Figure S8 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S5 and Figure S6 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplemental Figure S10 and Figure S11 from Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023
Publishes in
- Journal of Medicinal Chemistry×33
- Cancer Research×12
- Critical Care Medicine×2
- Molecular Cancer Therapeutics×2
- Nature Communications×2
Similar researchers
By research-topic overlap
- Longchuan Bai
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Shaomeng Wang
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Hannah M. Jacobs
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jeanne A. Stuckey
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Jennifer L. Meagher
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile